QuantaRx's follicle stimulating hormone immunoassay:
This article was originally published in Clinica
Executive Summary
The lateral flow immunoassay, called the QuantRx Biomedical Female Fertility test, is intended to aid women who are attempting to conceive. It can indirectly determine ovarian reserve - a measure of the capacity of the ovary to provides eggs that are capable of fertilisation - by measuring FSH in first morning urine. The over-the-counter test can produce results within 15 minutes, and can detect levels of FSH as low as 10ng/ml. The company is also developing a male fertility test, which is expected to reach the market in 2008.